Clinical trial
Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia:A Prospective, Double-Blind, Randomized, Placebo-Controlled Clinical Trial
NCT07182890 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia:A Prospective, Double-Blind, Randomized, Placebo-Controlled Clinical Trial
- Lead sponsor
- Xijing Hospital of Digestive Diseases
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 26, 2026
- Completion date
- May 31, 2027
- Enrollment
- 180 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anxiety, depression, functional dyspepsia, probiotics